Comment: POLAR gene profile can identify which patients can safely avoid radiation therapy after breast-conserving surgery

Updates from TAILORx and RxPONDER: Implications for practice

Interruption of endocrine therapy in young breast cancer patients does not increase the risk of short-term relapse

Genetic profiling identifies patients who can omit radiation therapy after breast-conserving surgery

Longest follow-up of patients with early breast cancer shows radiotherapy does not improve survival after 30 years

Optimisation of supportive, palliative and end of life care

What is required to advance data ethics, data sharing, and Open Science across LMICs

A genomic assay may predict long-term prognosis in premenopausal patients with HR+ early-stage breast cancer

Breast cancer in elderly patients: a clinicopathological review of a Nigerian database

Trastuzumab deruxtecan shows greater OS compared to trastuzumab emtansine in patients with HER2 + mBC

Adjuvant endocrine therapy +/- 1 year of everolimus fails to improve iDFS and OS in patients with high-risk HR+, HER2-negative BC

Camizestrant may be superior to fulvestrant in patients with hormone receptor-positive, HER2-negative breast cancer